2017~Until Now

Professor Renjie Jiao

Prof. Renjie Jiao was born in Jiangsu, China in the year of 1965. He obtained his Bachelor of Science majoring in Cell Biology from Peking University in 1987; Master of Science majoring in Cell Biology from the same university in 1991; and his PhD of Molecular Genetics and Developmental Biology from the University of Zurich in 1999. After a few years of postdoc training in Switzerland, he started his own lab in 2004 at the Institute of Biophysics, Chinese Academy of Sciences. He moved to Sino-French Hoffmann Institute, Guangzhou Medical University in 2017. He is currently an associate editor of “Journal of Genetics and Genomics”. A grant reviewer for Cancer Research UK; Austrian National Science Foundation; National Science Foundation of China; Ministry of Science and Technology, China. An evaluation expert for scientific awards organizations as Xplorer Prize; Macao Science and Technology Awards. A paper reviewer for scientific journals like «Nature Communications»、«Development»、«Journal of Cell Science»、«Journal of Molecular Cell Biology»、«Theranostics». He has published more than 70 papers in scientific journal like Nature Cell Biol., Dev. Cell, Cell Res., Nat. Commun., Cancer Res., Development, Oncogene, J. Neurosci.

2004~2007

Professor Tao Peng

Professor Peng received his B.Sc. degree in Biochemistry from Wuhan University, M.Sc. degree in Molecular Genetics from Drexel University (Philadelphia, USA) in 1994, and Ph.D. in Virology from University of Pennsylvania (Philadelphia, USA) in 1998. He has been engaged in postdoctoral research in SCRIPPS and University of California San Diego, and then in the research and development of antiviral drugs in pharmaceutical companies in the United States. He joined Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences in 2004 as the Principal Investigator of the Laboratory of Viral Immunology. In 2014, he was recruited by GMU as Professor, and during 2014-2017, he has functioned as director of SFHI.

Prof. Peng was selected into the “Hundred Talent Program (Chinese Academy of Sciences)” (2008), and the “Thousand Talents Program” (2013).  He was awarded Guangzhou “Innovative Leading Talents” (2013), “Scientific Chinese Annual Award” (2015), and “Overseas Chinese Contribution Award” (2014). He was supported by many grants such as the key construction project "basic medicine (immunology)" of Guangdong High-level University, the 973 project of the Ministry of Science and Technology, the major national research and development projects, the international cooperation projects of the Ministry of Science and Technology, the major science and technology projects of the academy of sciences, and the major science and technology projects of Guangdong province. He served as the mid-term and final evaluation expert for the project 973 of the Ministry of Science and Technology.

After served on its Editorial Board for two terms, he is now an Editor for the journal Antiviral Research. He also serves as reviewers of nearly 20 journals including FEBS J, Journal of Virology. He is the Chief Editor of “Isothermal Nucleic Acid Amplification Technology and Application” (a book designated for “isothermal nucleic acid amplification technology”, published by Science Press, China), and the Chief Editor of Clinical Virology (a book published by Science Press, China). He has obtained 8 patents including the international patent "Soluble Herpes Virus Protein Complex Vaccine". He has published nearly 60 scientific papers in the international Journal such as Journal of Virology, Hepatology, Cellular Microbiology, and Antiviral Research.

Honorary Director

Professor Jules A. Hoffmann

Professor Jules A. Hoffmann is a Luxembourg-born French biologist who received his doctoral degrees in biology and chemistry at the University of Strasbourg, France. He set up and headed the CNRS laboratory “Endocrinology and Immunology of Insects” within the CNRS Institut de Biologie Moléculaire et Cellulaire in Strasbourg, which he also directed from 1994 to 2006 and where he still works with his collaborators. He was President of the French Académie des Sciences in 2007 and 2008, and is a member of the Academy of Sciences of the United States of America, Germany and Russia, of the American Academy of Arts and Sciences and of the American Association for Cancer Research (AACR).

Professor Jules Hoffmann was awarded the 2011 Nobel Prize in Physiology or Medicine, together with Professor Bruce Beutler and Professor Ralph Steinman for "their discoveries concerning the activation of innate immunity".

Professor Hoffmann has also been awarded the Robert Koch Prize for Immunology (2004), the Balzan Prize for innate immunity together with Professor Bruce Beutler (2007), the Rosenstiel Award (with Professor Ruslan Medzhitov) for his work on immunity (2010), the Keio Medical Science Prize (with Professor Shizuo Akira) (2011), the 2011 Gairdner Award for medical research (with Professor Shizuo Akira) and the 2011 Shaw Prize in Life Science and Medicine (with Professor Bruce Beutler and Professor Ruslan Medzhitov). He also received the CNRS Gold Medal (2011). Professor Jules Hoffmann is Officier de la Légion d'Honneur in France and is an Immortel at the Académie Française (2012).